Information technology and adherence in ageing population with chronic diseases and polypharmacy

Information technology and adherence in ageing population with chronic diseases and polypharmacy

Activity details

Objective: To increase the adherence to treatment of older age adults with chronic diseases and polypharmacy (i) assessing the role of ICT - based solutions such as advanced processing of data, decision support applications and remote monitoring and consultation systems, and (ii) implementing tailored ICT- based interventions We expect that the knowledge that will be created will support stakeholders to take action in the direction of improving elderlies’ quality of life.
Action Group:
Other organisations participating in the commitment: 
Members of the EIPonAHA Action Groups
Lead organisation name: 
National Centre for Scientific Research (NCSR) "Demokritos"
Organisation country:
Contact person: 
Homer Papadopoulos
Contact person email: 
Homer Papadopoulos
Activity type:
Synergy led by:
Start date: 
15/04/2016
End date: 
31/12/2018
Last update: 04/09/2017

Current Status

Ongoing
The study will try to provide a reference on the requirements that an ICT adherence system should comply to and provide an architecture design methodology and the key technological building blocks that should be adopted. During the study we will use the lessons learnt in Italy by The Italian Medicines Agency (AIFA) consortium (involving Universities, Research Centers, Patient associations) through the Scientific Advisory Board on Adherence, SABA (results under publication). The barriers and results of this network and activities projects like SIMPATHY can be used to develop or scale up innovative approaches at the EU level supporting necessary changes in the direction of improving elderlies’ quality of life,

Results

Title Planned Deadline Current Status Category Attachments
Poster at ESPACOM 17/11/2016 Achieved Dissemination: Meetings, events, conferences

Outcomes

Indicator Target indicator Current status
Number of organisations informed about the activity of the Synergy 100 70